OSRH Stock Analysis: Buy, Sell, or Hold?
OSRH - OSR Holdings, Inc. Common Stock
$0.28
-0.02 (-6.07%)
▼
5d:
-12.34%
30d:
-38.44%
90d:
-45.7%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When OSRH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: OSRH is down 12.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: OSRH is down 12.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: OSRH is currently trading at $0.28, which is considered oversold relative to its 30-day fair value range of $0.35 to $0.48.
Technical Outlook: Technically, OSRH is in a strong downtrend. Immediate support is located at $0.25, while resistance sits at $0.84. Short-term momentum is weak, with the stock down 6.1% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $10.00 (+3510.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OSRH is in a strong downtrend. Immediate support is located at $0.25, while resistance sits at $0.84. Short-term momentum is weak, with the stock down 6.1% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $10.00 (+3510.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.35 -
$0.48
Company Quality Score
44/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
72.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-6.1%)
- BULLISH: Trading 3510.1% below Wall St target ($10.00)
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.35 -
$0.48
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.25
Resistance Level
$0.84
Current Trend
Strong Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Wall Street Target
$10.00
(+3510.1%)
Revenue Growth (YoY)
-72.2%
Share & Embed Analysis
Last updated: August 23, 2026 3:39 AM ET
Data refreshes hourly during market hours. Next update: 4:39 AM
Data refreshes hourly during market hours. Next update: 4:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OSRH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 33 SELL |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$834 | 34 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$281 | 55 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 49 HOLD |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$39 | 52 HOLD |
